Earnings FeedTerminal

⌘K

Home/Insiders/Piekos Brian

PB

SEC Insider//CIK 0001815308

Piekos Brian

CIK 00018153081 companyFRAMINGHAM, MA

Transactions

12

Companies

1

Filings

1

CIK

0001815308

Recent Transactions

12 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−4,471→ 10,529 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−4,471→ 10,529 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−4,471→ 10,529 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−4,471→ 10,529 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+15,000→ 15,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−15,000→ 65,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+15,000→ 15,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+15,000→ 15,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−15,000→ 65,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−15,000→ 65,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+15,000→ 15,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−15,000→ 65,000 total

Companies

1

KalVista Pharmaceuticals, Inc.
Chief Financial Officer
$KALV

Recent Filings

1

4
Piekos Brian
Nov 26, 2025

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov